Europe Patient Monitoring Market by Product (Cardiac Monitoring Devices, Blood Glucose Monitoring Systems, Hemodynamic/Pressure Monitoring Devices, Multi-parameter Monitoring Devices, Respiratory Monitoring Devices, Temperature Monitoring Devices, Fetal & Neonatal Monitoring Devices, Neuromonitoring Devices, Weight Monitoring Devices, and Other Devices), by Type (Conventional and Wireless), and by End User (Home Healthcare, Hospitals & Clinics, and Others) - Opportunity Analysis and Industry Forecast, 2024–2030

Europe Patient Monitoring Market

Industry:  Life Sciences & Healthcare | Publish Date: Feb 2024 | No of Pages:  182 | No. Tables:  132 | No. Figures:  97

Market Definition

The Europe Patient Monitoring Market size was valued at USD 12.53 billion in 2023, and is predicted to reach USD 21.21 billion by 2030, with a CAGR of 7.5% from 2024 to 2030. Patient monitoring is a crucial aspect of modern healthcare, involving the continuous or intermittent assessment of a patient's vital signs, physiological parameters, and overall health status throughout their medical treatment. This process employs a range of medical devices and technologies to collect, record, and analyze data such as blood pressure, heart rate, oxygen saturation, respiratory rate, temperature, and other vital signs.

The patient monitoring market encompasses the healthcare industry segment dedicated to developing, manufacturing, and distributing equipment and systems for consistently or periodically tracking and recording a patient's vital signs and health parameters. This market plays a critical role in various healthcare settings, from hospitals and intensive care units to outpatient clinics and home healthcare environments. By enabling the provision of appropriate care tailored to individual medical needs, patient monitoring ensures that patients receive the highest quality of care.

Government Initiatives Drives the Growth of Patient Monitoring Systems

Government initiatives in the Europe region play a crucial role in propelling the growth of the patient monitoring market. Governments, recognizing the importance of a resilient healthcare system, are channeling funds to upgrade healthcare infrastructure, encompassing hospitals and clinics. This facilitates the integration of cutting-edge technologies, including patient monitoring systems. Initiatives often encourage the adoption of modern healthcare technologies through incentives and supportive regulatory environments, fostering collaboration between the public and private sectors.

 

Rising Chronic Diseases Propels the Patient Monitoring Growth Over the Region

The rising incidence of chronic diseases, such as cardiovascular disorders, diabetes, and respiratory illnesses, is fueling the expansion of the patient monitoring market in Europe. Patient monitoring devices are critical for managing chronic conditions by providing real-time data on vital signs and medication adherence, enabling timely interventions and preventive measures. This growing burden of chronic diseases necessitates advanced healthcare solutions, leading to increased investment in patient monitoring technologies.

 

Connectivity Issues in Patient Monitoring Devices Restrain the Market Growth

One of the significant restraining factors in the patient monitoring market in Europe is the connectivity issues which pose a risk to real-time data transmission and communication between devices, impacting the timeliness and accuracy of patient information. Addressing these challenges is crucial for unlocking the full potential of patient monitoring technologies and ensuring their widespread adoption in the healthcare sector.

Introduction of AI and Machine Learning in Patient Monitoring Systems Create Ample Growth Opportunities

In Europe, Artificial Intelligence (AI) and Machine Learning (ML) are transforming the landscape of patient monitoring by enabling advanced analysis of extensive datasets. In this context, AI algorithms leverage historical patient data to identify subtle patterns and anomalies in vital signs and medical history. This capability allows for early detection of potential health issues before symptoms manifest, facilitating timely interventions.

Moreover, the integration of AI and ML supports the concept of personalized medicine, tailoring treatment plans based on individual patient characteristics and responses. These technologies contribute to risk stratification, helping healthcare providers prioritize interventions for patients at higher risk of developing specific medical conditions or complications.

Germany Holds the Dominant Market Share in Europe Patient Monitoring Market

The shifting demographic landscape marked by a steadily increasing aging population, stands as a pivotal driver propelling the Patient Monitoring Market. Conditions such as diabetes, cardiovascular diseases, and respiratory disorders are more common among the elderly, prompting a heightened demand for patient monitoring solutions. These technologies enable healthcare providers to remotely track vital signs, manage chronic illnesses, and respond promptly to emergent situations.

Ongoing technological advancements play a pivotal role in shaping the Patient Monitoring Market. The introduction of wearable devices, such as smartwatches and fitness trackers, equipped with advanced monitoring capabilities has gained prominence. These devices enable continuous tracking of vital signs, providing real-time health data to both healthcare professionals and patients. Additionally, the integration of remote monitoring systems allows for the tracking of patients' health status from a distance, enhancing accessibility to healthcare services.

U.K. to Witness Substantial Growth in the Europe Market

The surge in chronic diseases, encompassing conditions such as cardiovascular ailments, diabetes, and respiratory disorders, serves as a pivotal driver for the Patient Monitoring Market in the U.K. With an escalating need for continuous health surveillance, patient monitoring systems play a vital role in early detection, intervention, and management of chronic illnesses. These systems enable real-time tracking and analysis of essential health parameters, ensuring timely responses to abnormalities.

Government initiatives in the Europe region are crucial drivers for the growth of the patient monitoring market. Recognizing the significance of a robust healthcare system, governments allocate funds to enhance healthcare infrastructure, including hospitals and clinics, facilitating the integration of advanced technologies including patient monitoring systems. Initiatives often encourage the adoption of modern healthcare technologies through incentives and favorable regulatory environments, fostering collaboration between the public and private sectors.

 

Competitive Landscape

Various market players operating in the Europe patient monitoring market include Medtronic Plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Nihon Kohden Corporation, Abbott Laboratories, Masimo Corporation, Hill-Rom Holdings, Inc., Biotronik SE & Co. KG, Honeywell International, Inc., and others.

Europe Patient Monitoring Key Market Segments

By Product

  • Cardiac Monitoring Devices

    • Mobile Cardiac Telemetry Monitors

    • Electrocardiogram (ECG) Devices

    • Implantable Loop Recorders

    • Event Monitors

    • Smart/Wearable ECG Monitors

  • Blood Glucose Monitoring Systems

    • Self-Monitoring Blood Glucose Systems

    • Continuous Glucose Monitoring Systems

  • Hemodynamic/Pressure Monitoring Devices

    • Hemodynamic Monitors

    • Blood Pressure Monitors

    • Disposables 

  • Multi-Parameter Monitoring Devices

    • Low-Acuity Monitoring Device

    • Mid-Acuity Monitoring Devices

    • High-Acuity Monitoring Devices

  • Respiratory Monitoring Devices

    • Pulse Oximeters

    • Spirometers

    • Capnographs

    • Peak Flow Meters

  • Temperature Monitoring Device

    • Handheld Temperature Monitoring Devices

    • Table-Top Temperature Monitoring Devices

    • Wearable Continuous Monitoring Devices

    • Invasive Temperature Monitoring Devices

    • Smart Temperature Monitoring Devices

  • Fetal & Neonatal Monitoring Devices

    • Neonatal Monitoring Devices

    • Fetal Monitoring Devices

  • Neuromonitoring Devices

    • Electroencephalograph (EEG) Machines

    • Electromyography Machines

    • Cerebral Oximeter

    • Intracranial Pressure (ICP) Monitors

    • Magnetoencephalography (MEG) Machines

    • Transcranial Doppler (TCD) Machines

  • Weight Monitoring Devices

    • Digital

    • Analog

  • Others Devices

By Type

  • Conventional

  • Wireless

By End User

  • Home Healthcare

  • Hospitals & Clinics

  • Others

By Region

  • Europe

    • The U.K.

    • Germany

    • France    

    • Italy

    • Spain

    • Netherlands

    • Rest of Europe

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Market Size in 2023

USD 12.53 Billion

Revenue Forecast in 2030

USD 21.21 Billion

Revenue Growth Rate

CAGR of 7.5% from 2024 to 2030

Analysis Period

2023–2030

Base Year Considered

2023

Forecast Period

2024–2030

Market Size Estimation

Billion (USD)

Growth Factors

Government Initiatives Drives the Growth of Patient Monitoring Systems

Impact of Rising Chronic Diseases Propels the Patient Monitoring Growth over the region

Countries Covered

6

Companies Profiled

10

Market Share

Available for 10 companies

Customization Scope

Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

Test

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      EUROPE PATIENT MONITORING MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6      EUROPE PATIENT MONITORING MARKET BY PRODUCT

           6.1      OVERVIEW

           6.2      CARDIAC MONITORING DEVICES

                         6.2.1      CARDIAC MONITORING DEVICES MARKET, BY PRODUCT

                                          6.2.1.1      MOBILE CARDIAC TELEMETRY MONITORS MARKET, BY COUNTRY

                                          6.2.1.2      ELECTROCARDIOGRAM (ECG) DEVICES MARKET, BY COUNTRY

                                          6.2.1.3      IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY

                                          6.2.1.4      EVENT MONITORS MARKET, BY COUNTRY

                                          6.2.1.5      SMART/WEARABLE ECG MONITORS MARKET, BY COUNTRY

                         6.2.2      CARDIAC MONITORING DEVICES MARKET, BY COUNTRY

           6.3      BLOOD GLUCOSE MONITORING SYSTEMS

                         6.3.1      BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

                                          6.3.1.1      SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COUNTRY

                                          6.3.1.2      CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY

                         6.3.2      BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY

           6.4      HEMODYNAMIC/PRESSURE MONITORING DEVICES

                         6.4.1      HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY PRODUCT

                                          6.4.1.1      HEMODYNAMIC MONITORS MARKET, BY COUNTRY

                                          6.4.1.2      BLOOD PRESSURE MONITORS MARKET, BY COUNTRY

                                          6.4.1.3      DISPOSABLES MARKET, BY COUNTRY

                         6.4.2      HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY COUNTRY

           6.5      MULTI-PARAMETER MONITORING DEVICES

                         6.5.1      MULTI-PARAMETER MONITORING DEVICES MARKET, BY PRODUCT

                                          6.5.1.1      LOW-ACUITY MONITORING DEVICE MARKET, BY COUNTRY

                                          6.5.1.2      MID-ACUITY MONITORING DEVICES MARKET, BY COUNTRY

                                          6.5.1.3      HIGH-ACUITY MONITORING DEVICES MARKET, BY COUNTRY

                         6.5.2      MULTI-PARAMETER MONITORING DEVICES MARKET, BY COUNTRY

           6.6      RESPIRATORY MONITORING DEVICES

                         6.6.1      RESPIRATORY MONITORING DEVICES MARKET, BY PRODUCT

                                          6.6.1.1      PULSE OXIMETERS MARKET, BY COUNTRY

                                          6.6.1.2      SPIROMETERS MARKET, BY COUNTRY

                                          6.6.1.3      CAPNOGRAPHS MARKET, BY COUNTRY

                                          6.6.1.4      PEAK FLOW METERS MARKET, BY COUNTRY

                         6.6.2      RESPIRATORY MONITORING DEVICES MARKET, BY COUNTRY

           6.7      TEMPERATURE MONITORING DEVICE

                         6.7.1      TEMPERATURE MONITORING DEVICE MARKET, BY PRODUCT

                                          6.7.1.1      HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY

                                          6.7.1.2      TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY

                                          6.7.1.3      WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY COUNTRY

                                          6.7.1.4      INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY

                                          6.7.1.5      SMART TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY

                         6.7.2      TEMPERATURE MONITORING DEVICE MARKET, BY COUNTRY

           6.8      FETAL AND NEONATAL MONITORING DEVICES

                         6.8.1      FETAL AND NEONATAL MONITORING DEVICES MARKET, BY PRODUCT

                                          6.8.1.1      NEONATAL MONITORING DEVICES MARKET, BY COUNTRY

                                          6.8.1.2      FETAL MONITORING DEVICES MARKET, BY COUNTRY

                         6.8.2      FETAL AND NEONATAL MONITORING DEVICES MARKET, BY COUNTRY

           6.9      NEUROMONITORING DEVICES

                         6.9.1      NEUROMONITORING DEVICES MARKET, BY PRODUCT

                                          6.9.1.1      ELECTROENCEPHALOGRAPH (EEG) MACHINES MARKET, BY COUNTRY

                                          6.9.1.2      ELECTROMYOGRAPHY MACHINES MARKET, BY COUNTRY

                                          6.9.1.3      CEREBRAL OXIMETER MARKET, BY COUNTRY

                                          6.9.1.4      INTRACRANIAL PRESSURE (ICP) MONITORS MARKET, BY COUNTRY

                                          6.9.1.5      MAGNETOENCEPHALOGRAPHY (MEG) MACHINES MARKET, BY COUNTRY

                                          6.9.1.6      TRANSCRANIAL DOPPLER (TCD) MACHINES MARKET, BY COUNTRY

                         6.9.2      NEUROMONITORING DEVICES MARKET, BY COUNTRY

           6.10      WEIGHT MONITORING DEVICES

                         6.10.1      WEIGHT MONITORING DEVICES MARKET, BY PRODUCT

                                          6.10.1.1      DIGITAL MARKET, BY COUNTRY

                                          6.10.1.2      ANALOG MARKET, BY COUNTRY

                         6.10.2      WEIGHT MONITORING DEVICES MARKET, BY COUNTRY

           6.11      OTHERS DEVICES

                         6.11.1      OTHERS DEVICES MARKET, BY COUNTRY

7      EUROPE PATIENT MONITORING MARKET BY TYPE

           7.1      OVERVIEW

           7.2      CONVENTIONAL

                         7.2.1      CONVENTIONAL MARKET, BY COUNTRY

           7.3      WIRELESS

                         7.3.1      WIRELESS MARKET, BY COUNTRY

8      EUROPE PATIENT MONITORING MARKET BY END USER

           8.1      OVERVIEW

           8.2      HOME HEALTHCARE

                         8.2.1      HOME HEALTHCARE MARKET, BY COUNTRY

           8.3      HOSPITALS AND CLINICS

                         8.3.1      HOSPITALS AND CLINICS MARKET, BY COUNTRY

           8.4      OTHERS

                         8.4.1      OTHERS MARKET, BY COUNTRY

9     EUROPE PATIENT MONITORING MARKET, BY COUNTRY

           9.1     OVERVIEW

           9.2     GERMANY

                         9.2.1     EUROPE PATIENT MONITORING MARKET, BY PRODUCT

                         9.2.2     EUROPE PATIENT MONITORING MARKET, BY TYPE

                         9.2.3     EUROPE PATIENT MONITORING MARKET, BY END USER

           9.3     FRANCE

                         9.3.1     EUROPE PATIENT MONITORING MARKET, BY PRODUCT

                         9.3.2     EUROPE PATIENT MONITORING MARKET, BY TYPE

                         9.3.3     EUROPE PATIENT MONITORING MARKET, BY END USER

           9.4     ITALY

                         9.4.1     EUROPE PATIENT MONITORING MARKET, BY PRODUCT

                         9.4.2     EUROPE PATIENT MONITORING MARKET, BY TYPE

                         9.4.3     EUROPE PATIENT MONITORING MARKET, BY END USER

           9.5     SPAIN

                         9.5.1     EUROPE PATIENT MONITORING MARKET, BY PRODUCT

                         9.5.2     EUROPE PATIENT MONITORING MARKET, BY TYPE

                         9.5.3     EUROPE PATIENT MONITORING MARKET, BY END USER

           9.6     UNITED KINGDOM

                         9.6.1     EUROPE PATIENT MONITORING MARKET, BY PRODUCT

                         9.6.2     EUROPE PATIENT MONITORING MARKET, BY TYPE

                         9.6.3     EUROPE PATIENT MONITORING MARKET, BY END USER

           9.7     NETHERLANDS

                         9.7.1     EUROPE PATIENT MONITORING MARKET, BY PRODUCT

                         9.7.2     EUROPE PATIENT MONITORING MARKET, BY TYPE

                         9.7.3     EUROPE PATIENT MONITORING MARKET, BY END USER

           9.8     REST OF EUROPE

                         9.8.1     EUROPE PATIENT MONITORING MARKET, BY PRODUCT

                         9.8.2     EUROPE PATIENT MONITORING MARKET, BY TYPE

                         9.8.3     EUROPE PATIENT MONITORING MARKET, BY END USER

10   COMPANY PROFILES

           10.1   MEDTRONIC PLC

                         10.1.1   COMPANY OVERVIEW

                         10.1.2   COMPANY SNAPSHOT

                         10.1.3   OPERATING BUSINESS SEGMENTS

                         10.1.4   PRODUCT PORTFOLIO

                         10.1.5   BUSINESS PERFORMANCE

                         10.1.6   BUSINESS SEGMENTS

                         10.1.7   GEOGRAPHIC SEGMENTS

                         10.1.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.1.9   PRIMARY MARKET COMPETITORS

           10.2   KONINKLIJKE PHILIPS N.V.

                         10.2.1   COMPANY OVERVIEW

                         10.2.2   COMPANY SNAPSHOT

                         10.2.3   OPERATING BUSINESS SEGMENTS

                         10.2.4   PRODUCT PORTFOLIO

                         10.2.5   BUSINESS PERFORMANCE

                         10.2.6   BUSINESS SEGMENTS

                         10.2.7   GEOGRAPHIC SEGMENTS

                         10.2.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.2.9   PRIMARY MARKET COMPETITORS

           10.3   GE HEALTHCARE

                         10.3.1   COMPANY OVERVIEW

                         10.3.2   COMPANY SNAPSHOT

                         10.3.3   OPERATING BUSINESS SEGMENTS

                         10.3.4   PRODUCT PORTFOLIO

                         10.3.5   BUSINESS PERFORMANCE

                         10.3.6   BUSINESS SEGMENTS

                         10.3.7   GEOGRAPHIC SEGMENTS

                         10.3.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.3.9   PRIMARY MARKET COMPETITORS

           10.4   SIEMENS HEALTHINEERS

                         10.4.1   COMPANY OVERVIEW

                         10.4.2   COMPANY SNAPSHOT

                         10.4.3   OPERATING BUSINESS SEGMENTS

                         10.4.4   PRODUCT PORTFOLIO

                         10.4.5   BUSINESS PERFORMANCE

                         10.4.6   BUSINESS SEGMENTS

                         10.4.7   GEOGRAPHIC SEGMENTS

                         10.4.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.4.9   PRIMARY MARKET COMPETITORS

           10.5   NIHON KOHDEN CORPORATION

                         10.5.1   COMPANY OVERVIEW

                         10.5.2   COMPANY SNAPSHOT

                         10.5.3   OPERATING BUSINESS SEGMENTS

                         10.5.4   PRODUCT PORTFOLIO

                         10.5.5   BUSINESS PERFORMANCE

                         10.5.6   BUSINESS SEGMENTS

                         10.5.7   GEOGRAPHIC SEGMENTS

                         10.5.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.5.9   PRIMARY MARKET COMPETITORS

           10.6   ABBOTT LABORATORIES

                         10.6.1   COMPANY OVERVIEW

                         10.6.2   COMPANY SNAPSHOT

                         10.6.3   OPERATING BUSINESS SEGMENTS

                         10.6.4   PRODUCT PORTFOLIO

                         10.6.5   BUSINESS PERFORMANCE

                         10.6.6   BUSINESS SEGMENTS

                         10.6.7   GEOGRAPHIC SEGMENTS

                         10.6.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.6.9   PRIMARY MARKET COMPETITORS

           10.7   MASIMO CORPORATION

                         10.7.1   COMPANY OVERVIEW

                         10.7.2   COMPANY SNAPSHOT

                         10.7.3   OPERATING BUSINESS SEGMENTS

                         10.7.4   PRODUCT PORTFOLIO

                         10.7.5   BUSINESS PERFORMANCE

                         10.7.6   BUSINESS SEGMENTS

                         10.7.7   GEOGRAPHIC SEGMENTS

                         10.7.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.7.9   PRIMARY MARKET COMPETITORS

           10.8   HILL-ROM HOLDINGS, INC.

                         10.8.1   COMPANY OVERVIEW

                         10.8.2   COMPANY SNAPSHOT

                         10.8.3   OPERATING BUSINESS SEGMENTS

                         10.8.4   PRODUCT PORTFOLIO

                         10.8.5   BUSINESS PERFORMANCE

                         10.8.6   BUSINESS SEGMENTS

                         10.8.7   GEOGRAPHIC SEGMENTS

                         10.8.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.8.9   PRIMARY MARKET COMPETITORS

           10.9   BIOTRONIK SE AND CO. KG

                         10.9.1   COMPANY OVERVIEW

                         10.9.2   COMPANY SNAPSHOT

                         10.9.3   OPERATING BUSINESS SEGMENTS

                         10.9.4   PRODUCT PORTFOLIO

                         10.9.5   BUSINESS PERFORMANCE

                         10.9.6   BUSINESS SEGMENTS

                         10.9.7   GEOGRAPHIC SEGMENTS

                         10.9.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.9.9   PRIMARY MARKET COMPETITORS

           10.10   HONEYWELL INTERNATIONAL, INC.

                         10.10.1   COMPANY OVERVIEW

                         10.10.2   COMPANY SNAPSHOT

                         10.10.3   OPERATING BUSINESS SEGMENTS

                         10.10.4   PRODUCT PORTFOLIO

                         10.10.5   BUSINESS PERFORMANCE

                         10.10.6   BUSINESS SEGMENTS

                         10.10.7   GEOGRAPHIC SEGMENTS

                         10.10.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.10.9   PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 2. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 3. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 4. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 5. EVENT MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 6. SMART/WEARABLE ECG MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 7. CARDIAC MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 8. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 9. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 10. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 11. HEMODYNAMIC MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 12. BLOOD PRESSURE MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 13. DISPOSABLES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 14. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 15. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 16. MID-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 17. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 18. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 19. PULSE OXIMETERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 20. SPIROMETERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 21. CAPNOGRAPHS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 22. PEAK FLOW METERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 23. RESPIRATORY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 24. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 25. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 26. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 27. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 28. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 29. TEMPERATURE MONITORING DEVICE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 30. NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 31. FETAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 32. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 33. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 34. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 35. CEREBRAL OXIMETER, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 36. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 37. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 38. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 39. NEUROMONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 40. DIGITAL, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 41. ANALOG, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)

TABLE 42. WEIGHT MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 43. OTHERS DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 44. EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 45. CONVENTIONAL, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 46. WIRELESS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 47. EUROPE PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 48. HOME HEALTHCARE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 49. HOSPITALS AND CLINICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 50. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 51. EUROPE PATIENT MONITORING MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 52. GERMANY EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 53. GERMANY EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 54. GERMANY EUROPE PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 55. FRANCE EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 56. FRANCE EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 57. FRANCE EUROPE PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 58. ITALY EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 59. ITALY EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 60. ITALY EUROPE PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 61. SPAIN EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 62. SPAIN EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 63. SPAIN EUROPE PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 64. UNITED KINGDOM EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 65. UNITED KINGDOM EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 66. UNITED KINGDOM EUROPE PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 67. NETHERLANDS EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 68. NETHERLANDS EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 69. NETHERLANDS EUROPE PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 70. REST OF EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 71. REST OF EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 72. REST OF EUROPE PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 73. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 74. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS

TABLE 75. MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 76. MEDTRONIC PLC: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 77. MEDTRONIC PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 78. MEDTRONIC PLC: KEY STRATERGY

TABLE 79. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 80. KONINKLIJKE PHILIPS N.V.: OPERATING BUSINESS SEGMENTS

TABLE 81. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 82. KONINKLIJKE PHILIPS N.V.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 83. KONINKLIJKE PHILIPS N.V.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 84. KONINKLIJKE PHILIPS N.V.: KEY STRATERGY

TABLE 85. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 86. GE HEALTHCARE: OPERATING BUSINESS SEGMENTS

TABLE 87. GE HEALTHCARE: PRODUCT PORTFOLIO

TABLE 88. GE HEALTHCARE: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 89. GE HEALTHCARE: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 90. GE HEALTHCARE: KEY STRATERGY

TABLE 91. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT

TABLE 92. SIEMENS HEALTHINEERS: OPERATING BUSINESS SEGMENTS

TABLE 93. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO

TABLE 94. SIEMENS HEALTHINEERS: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 95. SIEMENS HEALTHINEERS: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 96. SIEMENS HEALTHINEERS: KEY STRATERGY

TABLE 97. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 98. NIHON KOHDEN CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 99. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO

TABLE 100. NIHON KOHDEN CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 101. NIHON KOHDEN CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 102. NIHON KOHDEN CORPORATION: KEY STRATERGY

TABLE 103. ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 104. ABBOTT LABORATORIES: OPERATING BUSINESS SEGMENTS

TABLE 105. ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 106. ABBOTT LABORATORIES: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 107. ABBOTT LABORATORIES: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 108. ABBOTT LABORATORIES: KEY STRATERGY

TABLE 109. MASIMO CORPORATION: COMPANY SNAPSHOT

TABLE 110. MASIMO CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 111. MASIMO CORPORATION: PRODUCT PORTFOLIO

TABLE 112. MASIMO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 113. MASIMO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 114. MASIMO CORPORATION: KEY STRATERGY

TABLE 115. HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT

TABLE 116. HILL-ROM HOLDINGS, INC.: OPERATING BUSINESS SEGMENTS

TABLE 117. HILL-ROM HOLDINGS, INC.: PRODUCT PORTFOLIO

TABLE 118. HILL-ROM HOLDINGS, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 119. HILL-ROM HOLDINGS, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 120. HILL-ROM HOLDINGS, INC.: KEY STRATERGY

TABLE 121. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT

TABLE 122. BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS

TABLE 123. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO

TABLE 124. BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 125. BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 126. BIOTRONIK SE AND CO. KG: KEY STRATERGY

TABLE 127. HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT

TABLE 128. HONEYWELL INTERNATIONAL, INC.: OPERATING BUSINESS SEGMENTS

TABLE 129. HONEYWELL INTERNATIONAL, INC.: PRODUCT PORTFOLIO

TABLE 130. HONEYWELL INTERNATIONAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 131. HONEYWELL INTERNATIONAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 132. HONEYWELL INTERNATIONAL, INC.: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

FIGURE 7. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 8. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 9. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 10. EVENT MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 11. SMART/WEARABLE ECG MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 12. CARDIAC MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 13. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 14. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 15. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 16. HEMODYNAMIC MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 17. BLOOD PRESSURE MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 18. DISPOSABLES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 19. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 20. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 21. MID-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 22. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 23. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 24. PULSE OXIMETERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 25. SPIROMETERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 26. CAPNOGRAPHS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 27. PEAK FLOW METERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 28. RESPIRATORY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 29. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 30. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 31. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 32. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 33. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 34. TEMPERATURE MONITORING DEVICE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 35. NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 36. FETAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 37. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 38. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 39. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 40. CEREBRAL OXIMETER, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 41. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 42. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 43. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 44. NEUROMONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 45. DIGITAL, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 46. ANALOG, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 47. WEIGHT MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 48. OTHERS DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 49. EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

FIGURE 50. CONVENTIONAL, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 51. WIRELESS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 52. EUROPE PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

FIGURE 53. HOME HEALTHCARE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 54. HOSPITALS AND CLINICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 55. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 56. EUROPE PATIENT MONITORING MARKET VALUE, BY REGION 2023-2030, (MILLION USD)

FIGURE 57. GERMANY EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 58. GERMANY EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 59. GERMANY EUROPE PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 60. FRANCE EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 61. FRANCE EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 62. FRANCE EUROPE PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 63. ITALY EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 64. ITALY EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 65. ITALY EUROPE PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 66. SPAIN EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 67. SPAIN EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 68. SPAIN EUROPE PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 69. UNITED KINGDOM EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 70. UNITED KINGDOM EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 71. UNITED KINGDOM EUROPE PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 72. NETHERLANDS EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 73. NETHERLANDS EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 74. NETHERLANDS EUROPE PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 75. REST OF EUROPE PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)

FIGURE 76. REST OF EUROPE PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)

FIGURE 77. REST OF EUROPE PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 78. MEDTRONIC PLC: NET SALES, (2021-2023)

FIGURE 79. MEDTRONIC PLC: PRIMARY MARKET COMPETITORS

FIGURE 80. KONINKLIJKE PHILIPS N.V.: NET SALES, (2021-2023)

FIGURE 81. KONINKLIJKE PHILIPS N.V.: PRIMARY MARKET COMPETITORS

FIGURE 82. GE HEALTHCARE: NET SALES, (2021-2023)

FIGURE 83. GE HEALTHCARE: PRIMARY MARKET COMPETITORS

FIGURE 84. SIEMENS HEALTHINEERS: NET SALES, (2021-2023)

FIGURE 85. SIEMENS HEALTHINEERS: PRIMARY MARKET COMPETITORS

FIGURE 86. NIHON KOHDEN CORPORATION: NET SALES, (2021-2023)

FIGURE 87. NIHON KOHDEN CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 88. ABBOTT LABORATORIES: NET SALES, (2021-2023)

FIGURE 89. ABBOTT LABORATORIES: PRIMARY MARKET COMPETITORS

FIGURE 90. MASIMO CORPORATION: NET SALES, (2021-2023)

FIGURE 91. MASIMO CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 92. HILL-ROM HOLDINGS, INC.: NET SALES, (2021-2023)

FIGURE 93. HILL-ROM HOLDINGS, INC.: PRIMARY MARKET COMPETITORS

FIGURE 94. BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)

FIGURE 95. BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS

FIGURE 96. HONEYWELL INTERNATIONAL, INC.: NET SALES, (2021-2023)

FIGURE 97. HONEYWELL INTERNATIONAL, INC.: PRIMARY MARKET COMPETITORS

KEY PLAYERS

  • Medtronic Plc

  • Koninklijke Philips N.V.

  • GE Healthcare

  • Siemens Healthineers

  • Nihon Kohden Corporation

  • Abbott Laboratories

  • Masimo Corporation

  • Hill-Rom Holdings, Inc.

  • Biotronik SE & Co. KG

  • Honeywell International, Inc.


Frequently Asked Questions
What is the market size of the Europe patient monitoring market in 2030?

According to Next Move Strategy Consulting, the market size of Europe patient monitoring is USD 12.53 billion in 2023.

What was the market size of the Europe patient monitoring market in 2023?

According to Next Move Strategy Consulting, the market size of Europe patient monitoring was USD 21.21 billion in 2023.

What role does artificial intelligence (AI) play in patient monitoring?

AI is used to analyze large datasets from patient monitoring devices, helping healthcare providers detect trends and anomalies and predict patient outcomes effectively.

What are the benefits of using wearable patient monitoring devices?

Wearable patient monitoring devices offer real-time data, improved patient comfort, and the ability to track health metrics continuously, which can aid in early disease detection and management.

Which are the top companies operating in the patient monitoring market?

The top companies operating in the patient monitoring market include Medtronic Plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, and Abbott Laboratories.